SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

CTech’s Book Review: What strategy really is and why so many organizations get it wrong

British Ambassador to Israel, Simon Walters: “If you build in Britain, we will back you”

The end-of-year tech layoffs are not a crisis - they mark a paradigm shift

MSC denies interest in acquiring ZIM

Buzz

Most popular

Daily

Weekly

1

Huang declares Israel Nvidia’s “second home” with record-breaking campus investment

2

Vega raises $120 million Series B as two-year-old cyber startup hits $700 million valuation

3

Cyera raises $400 million at $9 billion valuation in Blackstone-led round

4

Dell acquires AI data-infrastructure startup Dataloop in $120 million all-cash deal

5

“The acquisition of Armis marks a clear entry by ServiceNow into cybersecurity”

Oncology

6 stories about Oncology

Sai Jasti, senior VP and head of data science and AI at Bayer; Ofer Sharon, MD, physician and CEO of OncoHost

“Younger people are getting cancer more and more. We have to make kinder medicines.”

14.12.25|Zachy Hennessey

As AI hype accelerates, oncology’s real progress is happening quietly, driven by data, regulation, and the slow work of making cancer treatment more precise and sustainable

Protai Founders

Protai adds $12 million to Seed round as it aims to build oncology drug discovery pipeline

The Israeli startup, which has built a proteomics AI-based platform that comprehensively maps the course of a disease on the protein level, aims to better predict which patients will respond to a given drug as well as discover novel drug targets that were missed by genomic approaches

Nucleai raises $33 million for spatial biology drug development platform

22.03.22|Meir Orbach

The technology developed at the Israeli startup allows better prediction of the patient's response to specific oncological treatment, saves on the ongoing process of testing different drugs and improves the chances of the development of new cancer drugs

אוהד ארזי מנכ"ל זברה מדיקל

Israel’s Zebra Medical Vision gets its first FDA clearance in oncology

28.07.20|James Spiro

The new approval marks the sixth time the medical imaging company has earned FDA clearance

Oncology Company Alpha Tau Raises $29 Million

06.09.18|Hezi Sternlicht

Alpha Tau’s cancer treatment technology uses alpha radiation to treat solid tumors with radiation particles that are released inside the tumor, killing the surrounding cells

סרטן ריאות גידול סרטני

Israeli Oncology Company Alpha Tau is Raising Funds

22.08.18|Hezi Sternlicht

Alpha Tau is in the last stages of raising an investment of several tens of millions of dollars